Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
- B1059 MosaprideSummary: Selective 5HT4 agonist
- B2251 NaratriptanTarget: 5-HT1 ReceptorSummary: selective 5-HT1 receptor subtype agonist
- B1613 Pyridostigmine BromideSummary: Reversible cholinesterase inhibitor
- B1446 KetoprofenSummary: Dual COX1/2 inhibitor
- B2261 ZolmitriptanSummary: Potent 5-HT1B/1D/1F agonist
- B1134 Oxybutynin chlorideSummary: Anticholinergic medication
- B1632 ADX-47273Summary: mGluR5 receptor positive allosteric modulator, potent and selective
- B2231 Amitriptyline HClTarget: Trk Receptors|5-HT2 Receptors|Norepinephrine transporter|5-HT TransportersSummary: Serotonin /norepinephrine receptor/5-HT4/5-HT2 inhibitor
- B1442 AmpiroxicamSummary: COX inhibitor
- B1456 AsaraldehydeSummary: COX inhibitor